rs987237 — TFAP2B

TFAP2B — When Your Fat Cells Write Different Rules

TFAP2B (Transcription Factor AP-2 Beta) encodes a transcription factor expressed preferentially in adipose tissue¹¹ adipose tissue
Fat tissue, where this gene regulates the development and function of fat-storing cells. Unlike variants that affect how much you eat (appetite genes), TFAP2B influences how your body distributes and stores fat — particularly around the waist. The rs987237 variant was among the first three loci identified for central adiposity in large-scale genome-wide association studies.

The Mechanism

TFAP2B regulates adipocyte differentiation and adipokine expression²² adipokine expression
Signaling molecules secreted by fat cells, including leptin (satiety signal) and adiponectin (insulin sensitivity regulator). The G allele at rs987237 sits within an intronic regulatory region that alters TFAP2B expression in adipose tissue. Carriers of the G allele show lower circulating leptin levels³³ lower circulating leptin levels
Leptin tells the brain about fat stores; lower levels may impair satiety signaling (approximately 2.7 ng/ml reduction), suggesting functional consequences for how fat cells communicate with the rest of the body.

The Evidence

The landmark GWAS meta-analysis⁴⁴ landmark GWAS meta-analysis
Lindgren et al. Genome-wide association scan meta-analysis identifies three loci influencing adiposity and fat distribution. PLoS Genet, 2009 identified rs987237 as genome-wide significant for waist circumference (P = 1.9 x 10^-11) in a meta-analysis of 16 GWAS studies comprising 38,580 individuals with replication in up to 70,689 additional subjects.

The most striking finding involves gene-diet interaction. In a clinical trial of 771 participants⁵⁵ clinical trial of 771 participants
Stocks et al. TFAP2B influences the effect of dietary fat on weight loss under energy restriction. PLoS ONE, 2012, TFAP2B rs987237 modified the effect of dietary fat on weight loss with a P-value for interaction of 0.00007. AA homozygotes lost 1.0 kg more on low-fat diets, while GG homozygotes lost 2.6 kg more on high-fat diets. This suggests opposite optimal dietary strategies depending on genotype.

A follow-up in the DiOGenes trial⁶⁶ DiOGenes trial
Stocks et al. TFAP2B-dietary protein and glycemic index interactions and weight maintenance after weight loss in the DiOGenes trial. Hum Hered, 2013 found that TFAP2B also interacts with dietary protein content during weight maintenance, though the pattern differed from the weight-loss phase — suggesting context-dependent gene-diet interactions.

In a study of 13,507 adult Danes⁷⁷ study of 13,507 adult Danes
Bille et al. Implications of central obesity-related variants in LYPLAL1, NRXN3, MSRA, and TFAP2B on quantitative metabolic traits in adult Danes. PLoS ONE, 2011, the variant showed nominal associations with central obesity measures and was associated with reduced leptin levels.

Practical Actions

If you carry the G allele, you may respond differently to dietary fat levels during weight management. While GG homozygotes paradoxically appear to lose more weight on higher-fat diets, this genotype is also associated with greater central fat distribution. Monitoring your waist circumference and waist-to-hip ratio provides more meaningful feedback than weight alone.

Interactions

TFAP2B sits in the same biological context as other central adiposity loci. Carriers of risk alleles at both rs987237 (TFAP2B) and rs7903146 (TCF7L2) face compounded effects on fat distribution and metabolic risk, since both genes influence adipocyte function through different pathways — TFAP2B via adipokine regulation and TCF7L2 via Wnt signaling in pancreatic beta cells.